Antibodies under a microscope

Ab03000-10.0

Anti-TRKB [C2], Human IgG1, kappa

Description

Recombinant monoclonal antibody to TRKB. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma C2.

Target

TRKB

Target Alias Names

NTRK2, Trk-B, GP145-TrkB, TrkB tyrosine kinase, Tropomyosin-related kinase, BDNF/NT-3 growth factors receptor, Neurotrophic tyrosine kinase receptor type 2, Tropomyosin receptor kinase B, tyrosine receptor kinase B

Isotype/Mimetic

IgG1

Animal-Derived Biomaterials Used

No

Sequence Available

No

Original Discovery Methods

Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences

Original Discovery Information Provided On Datasheet

Yes

Antibody/Binder Origins

Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression